EVOLVING AZIMUTH IN MUSA CONTEXT
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
About this trial
Non-pharmacological, randomized, nonprofit medical device intervention. The study aims to identify the positive impacts (co-creation), and negative impacts (co-destruction), resulting from the use of telemedicine, and, in particular, the telemonitoring service for patients with heart failure
Eligibility criteria
Qualifiers
Have been diagnosed with chronic CS according to the ESC guidelines;
Over 18 years of age;
Patients admitted to hospital or with access to first aid within the last year;
Smartphome that meets the digital requirements (ie Android or iOS able to download and use the application);
Disqualifiers
Severe psychiatric disorder
Inability to use portable technologies
Patients unable to use the equipment provided
Patients who deny consent to study participation
Trial design
Treatments tested in this trial
- Telemonitoring app
Treatment groups
184 Participants
are divided into 2 treatment groupsSponsors and collaborators
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Lead sponsor
ASST Grande Ospedale Metropolitano Niguarda
Collaborator
University of Milan
Collaborator
Source ClinicalTrials.gov